Good Laboratory Practice (GLP): GLP is a set of principles and standards designed to ensure the quality and integrity of non-clinical laboratory studies. It covers aspects such as study design, conduct, data recording, and Drug Pharma Testing lab reporting. Compliance with GLP is essential for data acceptance by regulatory authorities. Good Clinical Practice (GCP): GCP guidelines ensure that clinical trials are conducted ethically, with the safety of participants as the top priority, and that the data generated is reliable and accurate. Compliance with GCP is crucial for the approval of new drugs or pharmaceutical products.

International Council for Harmonisation (ICH) Guidelines: ICH is a global organization that develops guidelines to ensure the harmonization of regulatory requirements for pharmaceuticals. ICH guidelines cover various aspects of drug development, including quality, safety, efficacy, and multidisciplinary topics. Current Good Manufacturing Practice (cGMP): cGMP regulations establish standards for the design, monitoring, and control of manufacturing processes and facilities. Adherence to cGMP ensures that pharmaceutical products are consistently produced and controlled to meet quality standards.

Pharmacopeias: Pharmacopeias are authoritative books containing standards for drugs and pharmaceutical substances. Examples include the United States Pharmacopeia (USP) and the European Pharmacopoeia (Ph. Eur.), which outline testing methods, specifications, and acceptance criteria for drugs. Risk Management and Risk Assessment: Companies are often required to perform risk assessments and implement risk management plans to identify and mitigate potential risks associated with drug development and testing.

Visit Here: https://isspllab.com/services-pharmaceutical-products/